CD46 and infection: Nonetheless, infections with either the serum samples (Figure 4A) or input viruses (Figure 4C) on MDBK, CD46Δ, and CD46 A82LPTFS cells showed that the PI-86-2022 virus was capable of infecting both of the CD46-edited cell lines more efficiently compared to the original PI-86-2021 isolate.